Institute of Human Virology, Nigeria

What Institute of Human Virology, Nigeria does

The Institute of Human Virology, Nigeria (IHVN) is a private, non-governmental organization founded in 2004 as an affiliate of the Institute of Human Virology at the University of Maryland School of Medicine. Headquartered in Abuja, IHVN delivers prevention, care, treatment, and capacity-building services for HIV/AIDS, tuberculosis, malaria, COVID-19, and increasingly cancer across at least eight Nigerian states (Nasarawa, Rivers, Katsina, FCT, Lagos, Ogun, Oyo, and Osun). It implements a portfolio of donor-funded programs rather than commercial products: ASPIRE (PEPFAR/CDC HIV response in four states), the USAID TB LON 3 project across southwestern Nigeria, the Global Fund Grant Cycle 7 (GC7) for combined TB/HIV programming, the IMPACT malaria project, the ENHANCE centralized laboratory initiative, and the NIH-funded EXPAND Nigeria research training program. The organization also operates the International Research Center of Excellence (IRCE), a seven-story, two-tower research facility commissioned in Abuja in 2023 that houses advanced laboratories in immunology, virology, molecular pathology, clinical diagnostics, and biorepositories, backed by a Laboratory Information Management System (LIMS) for centralized sample and result management.

IHVN reaches beneficiaries through an event-driven model that combines direct service delivery embedded in government health facilities, community outreach via peer educators and Operation Triple Zero support groups, and partnerships with civil society organizations. Services are provided free of charge; revenue is grant-based, with no commercial pricing model. Major funding sources are PEPFAR through CDC, the Global Fund to Fight AIDS Tuberculosis and Malaria, USAID, the U.S. National Institutes of Health, and the Government of Nigeria via NACA, NASCP, NTBLCP, and NMEP. The organization also engages in digital health innovation (QuantifyNG AI supply-chain platform, electronic health records), research integrity advocacy (EXCEL-RITE conference with NHREC), and convening (IRCE Annual Scientific Symposium).

With 10,000+ employees and a multi-departmental structure covering prevention, care and treatment, clinical laboratory services, strategic information, internal audit, finance, grants management, and supply chain, IHVN functions as one of the largest nonprofit health implementing partners in Nigeria. Its competitive position rests on formal affiliation with the University of Maryland School of Medicine, embedded presence in public-sector health facilities, and accreditation as a recognized implementing partner under Nigerian government health programs.

Name

Institute of Human Virology, Nigeria

Legal name

Institute of Human Virology, Nigeria

Website

https://ihvnigeria.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

10,001+ employees

Short description

The Institute of Human Virology, Nigeria is a 10,000+-employee nonprofit founded in 2004 that implements donor-funded HIV/AIDS, tuberculosis, malaria, and cancer programs across eight Nigerian states, operating the IRCE research facility and a portfolio of PEPFAR, Global Fund, USAID, and NIH-backed projects.

Ownership category

akta.pro rank

Product category

Public Health Services

NAICS

Voluntary Health Organizations (813212), Other Grantmaking and Giving Services (813219)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE)

akta.pro secondary industries

Infectious Disease & Immunization Program Funding (HLAJALAH), Immunization & Vaccine Delivery Programs (BPADAIAB), Global Health Financing Mechanisms (HLAJAKAC)

Keywords

• HIV/AIDS treatment
• Tuberculosis programs
• Malaria prevention
• Public health services
• Health capacity building

Headquarters

HQ city

Abuja

HQ country

Nigeria

HQ region

Africa

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Donor/Funder Grants: IHVN operates primarily as a grant-funded organization receiving support from international donors. Major funding sources include PEPFAR through CDC, Global Fund to Fight AIDS Tuberculosis and Malaria, and government of Nigeria partnerships.
2. Healthcare Service Implementation: IHVN implements health programs as an implementing partner, delivering prevention, care, and treatment services for HIV, TB, malaria, and other infectious diseases in partnership with government and international organizations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

IHVN implements donor-funded public health programs delivering prevention, care, and treatment services for HIV/AIDS, tuberculosis, and malaria across Nigeria. The organization operates as a portfolio of integrated programs including PEPFAR-funded ASPIRE, USAID TB LON 3, Global Fund GC7, IMPACT malaria, and ENHANCE laboratory services, combined with capacity building, operational research, and the IRCE research facility.

Product overview

The Institute of Human Virology Nigeria (IHVN) is a healthcare organization established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine. Rather than a single unified product, IHVN operates as a portfolio of interconnected health programs, research initiatives, and capacity-building projects. The core offerings include HIV/AIDS programs (ASPIRE), tuberculosis initiatives (USAID TB LON 3), malaria interventions (IMPACT), and laboratory services (ENHANCE). The International Research Center of Excellence (IRCE) serves as the research backbone, hosting the Annual Scientific Symposium and conducting collaborative research. The EXCEL-RITE Conference represents the organization's research ethics and integrity training initiative. These programs work together to provide comprehensive health service implementation, capacity building, and research across Nigeria.

Differentiator

Problem solved

Functional benefit

Products and services

• ASPIRE Project ACTION to Sustain Precision and Integrated HIV Response towards Epidemic Control project funded by PEPFAR through CDC, focused in Nasarawa State, Rivers State, Katsina State and Federal Capital Territory, delivering HIV prevention, testing, care, and treatment services.
• GF GC7 Project Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Cycle 7 project aimed at increasing identification of all forms of TB in both the private sector and the community under guidance of NASCP, NTBLCP, and NACA.
• USAID TB LON 3 Project Five-year USAID/Nigeria Tuberculosis Local Organization Network project scaling up tuberculosis services in Lagos, Ogun, Oyo, and Osun states, engaging stakeholders in strengthening a resilient system for sustainable TB control.
• IMPACT Project Immunization and Malaria Progress by Accelerating Coverage and Transforming Services project promoting uptake of malaria prevention and treatment services in rural communities under guidance of the National Malaria Elimination Program.
• ENHANCE Project Enhanced and Sustainable Integrated Laboratory Services for HIV, TB, and Other Pathogens supporting government response to HIV epidemic control through an optimized centralized laboratory information management system.
• EXPAND Nigeria Project Expanding the Pool of Independent Investigators in Implementation Science in Nigeria through HIV Research training program addressing research leadership gaps among investigators, funded by NIH Fogarty.
• International Research Center of Excellence (IRCE) Seven-story, two-tower research facility in Cadastral Zone, Abuja established to promote collaborative research in diseases of relevance to local community, non-communicable diseases, and emerging infectious diseases, housing world-class laboratories in Immunology and Virology, Molecular Pathology, Clinical and Molecular Diagnostics, and Biorepositories.

Quantifiable outcome

• 20 million+ individuals counselled, tested and received HIV results
• +4 more outcomes

Named customers5 records

Segments7 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered major, core and minor.

• National Health Research Ethics Committee (NHREC)majorStrategic or Co-development Partner · 28 April 2025NHREC partnered with IHVN to host the EXCEL-RITE conference on research integrity, ethics, and leadership in research.
• University of Maryland Baltimore (UMB)coreStrategic or Co-development PartnerIHVN was established as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine. UMB provides technical collaboration, capacity building, and research mentorship.
• Institute of Human Virology (IHV.org)coreStrategic or Co-development PartnerParent organization affiliation providing technical guidance, research collaboration, and institutional support for HIV and infectious disease programs.
• Nigeria Centers for Disease Control (NCDC)majorStrategic or Co-development PartnerIHVN partners with NCDC for COVID-19 response including laboratory technical support, infection prevention control training, and contribution to disease surveillance and research.
• National AIDS and STDs Control Programme (NASCP)majorStrategic or Co-development PartnerGovernment program providing guidance for IHVN's HIV programming under GC7 Global Fund grant.
• National TB and Leprosy Control Programme (NTBLCP)majorStrategic or Co-development PartnerGovernment program providing guidance for IHVN's TB programming under GC7 Global Fund grant and implementation support.
• National Agency for the Control of AIDS (NACA)majorStrategic or Co-development PartnerGovernment agency providing oversight and coordination for HIV response in Nigeria.
• National Malaria Elimination Program (NMEP)majorStrategic or Co-development PartnerGovernment program guiding IHVN's malaria programming through IMPACT project for promoting uptake of malaria prevention and treatment services.
• Association of Positive Youths in Nigeria (APYIN)majorStrategic or Co-development PartnerIHVN partners with APYIN to coordinate provision of adolescent and youth-friendly health services and Operation Triple Zero Strategy implementation at facilities and community level.
• Baze UniversityminorStrategic or Co-development PartnerIHVN Campus is located after Baze University in Abuja, establishing geographic proximity for potential academic collaboration.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• John Snow, Inc. (JSI): US-based public health consulting and implementation firm with extensive USAID- and PEPFAR-funded work in HIV, RMNCH, and supply chain across developing countries. Comparable as a large, multi-disease, donor-funded implementer with global footprint.
• ICAP at Columbia University: Major PEPFAR-funded global health implementing partner affiliated with Columbia University, operating across multiple African countries including Nigeria. Comparable as a large university-affiliated NGO implementing HIV/TB programs with embedded research capacity.
• Clinton Health Access Initiative (CHAI): Global health NGO working in HIV, TB, malaria, and health systems across 30+ low- and middle-income countries, including Nigeria. Comparable as a multi-disease, donor-funded implementer leveraging grant capital to deliver health programs at scale.
• Management Sciences for Health (MSH): Global health non-profit implementing USAID- and donor-funded programs in HIV, TB, malaria, and health systems strengthening across Africa and Asia. Comparable as a multi-disease, grant-funded implementer with strong government-embedded distribution.

Emerging players

• Resolve to Save Lives: Global health non-profit with strong Africa presence, working on epidemic preparedness, malaria, and cardiovascular disease. Comparable as a donor-funded global health NGO scaling integrated public health programs in low-resource settings.
• Centre for Infectious Disease Research in Zambia (CIDRZ): Zambian non-profit affiliated with the University of Alabama at Birmingham, implementing PEPFAR-funded HIV/TB programs with embedded research capacity. Comparable as an African university-affiliated NGO operating the same implementing-partner model as IHVN.

Direct peers

• AIDS Healthcare Foundation (AHF): Global non-profit providing HIV/AIDS medical care and treatment across 45+ countries, including Nigeria. Comparable as a high-volume HIV treatment and testing provider operating in a similar donor-funded environment.
• APIN Public Health Initiatives: A leading Nigerian non-profit and PEPFAR implementing partner delivering HIV/AIDS, TB, and reproductive health services across multiple Nigerian states. Directly comparable as a Nigerian HIV/TB grant-funded implementer competing for the same donor pools.
• Elizabeth Glaser Pediatric AIDS Foundation (EGPAF): Global non-profit focused on HIV/AIDS prevention, care, and treatment, particularly pediatric HIV, with operations in multiple African countries. Directly comparable as a PEPFAR/CDC-funded HIV implementer reliant on similar donor funding architecture.

Regional players

• Society for Family Health (SFH) Nigeria: Nigerian non-profit focused on reproductive health, HIV prevention, and malaria, working with USAID, Global Fund, and private-sector partners. Comparable as a Nigerian NGO competing for the same donor-funded health-program space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ihvnigeria

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Human Virology, Nigeria